glp-1 agonists and pancreatitis Frontiers glp-1 pancreatitis law firm in
Description
16 Particularly the effects of these medications have covered importance in diseases closely related to obesity and DM such as CKD, cardiovascular disease and MASH
USA 89 , 86418645 (1992)
5 Future research outlook Over a relatively short period, obesity is a significant public health problem rising
The most common side effects of these medications are gastrointestinal (GI) issues like nausea, diarrhea, and abdominal pain
More severe side effects include pancreatitis (inflammation of the pancreas), gallbladder issues, and potential interactions with other medications
